Norion Cancer Immunotherapy Research
SHORT CODE
NCIR
MODEL
Continuous publication
STATUS
Open for submissions
Aims and scope
International original research across cancer immunotherapy. Norion Cancer Immunotherapy Research publishes continuously: accepted articles appear the day of acceptance, each with its own article number in the year's rolling volume. Every submission is peer reviewed, and every decision rests with the journal's editors.